<p>Southpoint Capital Advisors LP, a 10% owner, reported a disposal of common shares of Fennec Pharmaceuticals Inc. The Form 4 was filed by more than one reporting person, including Southpoint Capital Advisors LP and other reporting beneficial owners. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001012975-25-000985), on December 29, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

Southpoint Capital Advisors Reports Sale of Fennec Pharmaceuticals Common Shares